A case of epidermal growth factor receptor–mutant lung cancer with transformation from adenocarcinoma into small cell carcinoma suggested by histological investigation of skin metastasis
Haruka Omasa
Department of Dermatology, Keio University School of Medicine, Tokyo, Japan
Search for more papers by this authorCorresponding Author
Risa Kakuta
Department of Dermatology, Keio University School of Medicine, Tokyo, Japan
Correspondence
Risa Kakuta, Department of Dermatology, Keio University School of Medicine, 35 Shinanomachi, Shinjukuku, Tokyo 160-8582, Japan.
Email: [email protected]
Search for more papers by this authorHideki Terai
Keio Cancer Center (Respiratory Medicine), Keio University School of Medicine, Tokyo, Japan
Search for more papers by this authorMiho Kawaida
Department of Surgical Pathology, Ito Hospital, Tokyo, Japan
Search for more papers by this authorIkuko Hirai
Department of Dermatology, Keio University School of Medicine, Tokyo, Japan
Search for more papers by this authorKana Tamura
Department of Dermatology, Keio University School of Medicine, Tokyo, Japan
Search for more papers by this authorYoshihiro Ito
Department of Dermatology, Keio University School of Medicine, Tokyo, Japan
Search for more papers by this authorAyano Fukushima-Nomura
Department of Dermatology, Keio University School of Medicine, Tokyo, Japan
Search for more papers by this authorMasayuki Amagai
Department of Dermatology, Keio University School of Medicine, Tokyo, Japan
Search for more papers by this authorHayato Takahashi
Department of Dermatology, Keio University School of Medicine, Tokyo, Japan
Search for more papers by this authorHaruka Omasa
Department of Dermatology, Keio University School of Medicine, Tokyo, Japan
Search for more papers by this authorCorresponding Author
Risa Kakuta
Department of Dermatology, Keio University School of Medicine, Tokyo, Japan
Correspondence
Risa Kakuta, Department of Dermatology, Keio University School of Medicine, 35 Shinanomachi, Shinjukuku, Tokyo 160-8582, Japan.
Email: [email protected]
Search for more papers by this authorHideki Terai
Keio Cancer Center (Respiratory Medicine), Keio University School of Medicine, Tokyo, Japan
Search for more papers by this authorMiho Kawaida
Department of Surgical Pathology, Ito Hospital, Tokyo, Japan
Search for more papers by this authorIkuko Hirai
Department of Dermatology, Keio University School of Medicine, Tokyo, Japan
Search for more papers by this authorKana Tamura
Department of Dermatology, Keio University School of Medicine, Tokyo, Japan
Search for more papers by this authorYoshihiro Ito
Department of Dermatology, Keio University School of Medicine, Tokyo, Japan
Search for more papers by this authorAyano Fukushima-Nomura
Department of Dermatology, Keio University School of Medicine, Tokyo, Japan
Search for more papers by this authorMasayuki Amagai
Department of Dermatology, Keio University School of Medicine, Tokyo, Japan
Search for more papers by this authorHayato Takahashi
Department of Dermatology, Keio University School of Medicine, Tokyo, Japan
Search for more papers by this author
REFERENCES
- 1Oser MG, Niederst MJ, Sequist LV, Engelman JA. Transformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of origin. Lancet Oncol. 2015; 16: e165–e172.
- 2Oxnard GR, Arcila ME, Sima CS, Riely GJ, Chmielecki J, Kris MG, et al. Acquired resistance to EGFR tyrosine kinase inhibitors in EGFR-mutant lung cancer: distinct natural history of patients with tumors harboring the T790M mutation. Clin Cancer Res. 2011; 17: 1616–1622.
- 3Ishioka K, Yasuda H, Hamamoto J, Terai H, Emoto K, Kim TJ, et al. Upregulation of FGF9 in lung adenocarcinoma Transdifferentiation to small cell lung cancer. Cancer Res. 2021; 81: 3916–3929.
- 4Offin M, Chan JM, Tenet M, Rizvi HA, Shen R, Riely GJ, et al. Concurrent RB1 and TP53 alterations define a subset of EGFR-mutant lung cancers at risk for histologic transformation and inferior clinical outcomes. J Thorac Oncol. 2019; 14: 1784–1793.
- 5Lee JK, Lee J, Kim S, Kim S, Youk J, Park S, et al. Clonal history and genetic predictors of transformation into small-cell carcinomas from lung adenocarcinomas. J Clin Oncol. 2017; 35: 3065–3074.
